The intricate mechanisms underlying pathophysiology and progression of diabetes involve a complex interplay of genetic, metabolic, and immune factors. Type 1 diabetes results from autoimmune destruction of pancreatic beta cells, leading to absolute insulin deficiency, whereas type 2 diabetes is primarily driven by insulin resistance and progressive beta-cell dysfunction. Chronic hyperglycemia induces oxidative stress and inflammation, accelerating vascular and neural complications. Key signaling pathways, such as those involving insulin receptor substrates and glucose transporters, play crucial roles in disease development. Recent studies highlight the impact of gut microbiota, mitochondrial dysfunction, and lipid metabolism on diabetes progression. Understanding these molecular and cellular alterations is vital for developing targeted therapies aimed at preserving beta-cell function, enhancing insulin sensitivity, and preventing long-term complications.
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Important roles and mechanisms of novel calcium signaling in diabetes-induced vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, Belize Bible College, Belize
Title : The menopausal mind: Reframing female senescence as a neuroendocrine disorder with root cause management strategies
Amy Gutman, AdventHealth; Tough Love MD, United States
Title : Bridging the gap: Coaching patients on GLP-1s for sustainable outcomes beyond the prescription
Keith Hersey, Master Your GLP-1, United States